CDKN2A and neoplasm: Indeed, Leedham et al. demonstrated that deep esophageal glands and their associated ducts that are capable of harboring CDKN2A and TP53 mutations [36] can be found outside the depth of RFA (~0.5 mm) [37], which may permit regrowth of neoplasia prior to the patient’s next endoscopy.